Cytopoint is an injectable treatment for dogs that stops allergic itching by neutralizing a specific itch-signaling protein before it ever reaches the brain. Unlike broad-spectrum medications, it works outside the cell, targeting only the single molecule most responsible for the scratching, licking, and chewing that make allergic skin disease miserable for dogs. Most dogs see meaningful itch relief within one to three days of a single shot, and that relief typically lasts four to eight weeks.
The Itch Signal Cytopoint Blocks
In dogs with atopic dermatitis (allergic skin disease), the immune system overreacts to environmental triggers like pollen, dust mites, or mold. One result of that overreaction is a flood of a protein called interleukin-31, or IL-31. This protein binds to receptors on nerve cells in the skin and sends a powerful “itch now” signal to the brain. The dog scratches, licks, or chews in response, which damages the skin barrier and often leads to secondary infections, hot spots, and hair loss.
Cytopoint (the active ingredient is lokivetmab) is a monoclonal antibody, a lab-engineered protein designed to act like the antibodies a dog’s immune system naturally produces. Once injected under the skin, it circulates in the bloodstream and locks onto IL-31 molecules before they can reach nerve receptors. With IL-31 neutralized, the itch signal never fires. The antibody doesn’t enter cells and doesn’t suppress the broader immune system. It simply intercepts that one chemical messenger.
How Quickly It Works
In clinical studies, 47% of dogs achieved treatment success within 24 hours of their injection, and 77% reached that threshold by day three. That timeline is slightly slower than oral itch medications, which can begin working within four hours, but most owners notice a clear reduction in scratching within the first day or two. The injectable format means there’s no daily pill to remember, and the effects of a single dose last long enough to space visits four to eight weeks apart.
The antibody has a half-life of about 16 days, meaning the body gradually breaks it down over several weeks. Some dogs hold their relief for the full eight weeks; others start scratching again closer to four. Your vet will adjust the schedule based on how your dog responds.
How Cytopoint Compares to Apoquel
Apoquel (oclacitinib) is the other widely prescribed option for allergic itch in dogs, and the two work in fundamentally different ways. Apoquel is a pill that enters cells and blocks an entire signaling pathway responsible for inflammation and itch. That pathway carries signals from multiple immune proteins, not just IL-31, so Apoquel has a broader anti-inflammatory effect. It also means it interacts more with the immune system’s internal machinery.
Cytopoint stays outside the cell entirely. It targets only IL-31, leaving other immune functions untouched. This narrower approach gives it a more favorable safety profile, particularly for dogs that need long-term treatment or have other health conditions where immune suppression is a concern. The tradeoff is that if a dog’s itch is driven by immune signals beyond IL-31, Cytopoint alone may not be enough.
In terms of speed, Apoquel has the edge, often reducing itch within hours of the first dose. Cytopoint’s 24-to-72-hour window is still fast, but owners looking for same-day relief may notice the difference. Some vets use both together during flare-ups, starting Apoquel for immediate control and letting Cytopoint take over for sustained relief.
Side Effects and Safety
Cytopoint has one of the more favorable safety profiles among long-term allergy treatments for dogs. Because it mimics a natural antibody and targets a single protein outside the cell, it causes minimal systemic immunosuppression. Studies comparing it to cyclosporine, another common long-term option, found Cytopoint had better tolerability.
That said, side effects do occur. In clinical data, the most commonly reported were vomiting (about 15.5% of treated dogs), diarrhea (13.4%), and lethargy (9.9%). Less common effects included loss of appetite (4.9%), bacterial skin infections (7%), and ear infections (5.6%). Allergic reactions to the injection itself appear to be rare. In at least one published study, no hypersensitivity reactions were observed immediately after injection in any of the treated dogs.
The gastrointestinal symptoms (vomiting, diarrhea) tend to be temporary. Serious neurological, behavioral, or musculoskeletal problems have not been identified as treatment-related in published studies.
What to Expect at the Vet
Cytopoint is given as a subcutaneous injection, similar to a vaccine. The visit is quick. Your vet calculates the dose based on your dog’s body weight, using a minimum of 2 mg per kilogram. The medication comes in four vial sizes (10 mg, 20 mg, 30 mg, and 40 mg), and larger dogs may need multiple vials to reach the correct dose. A 10-pound dog might need a single small vial, while a 90-pound dog could require three.
There’s no at-home medication to give afterward. You simply watch for improvement over the next one to three days and schedule the next injection when symptoms begin to return, typically somewhere in that four-to-eight-week window. Over time, your vet will dial in the right interval for your dog.
Cost Considerations
Because dosing is weight-based and requires more vials for bigger dogs, cost scales directly with size. A single injection typically runs $50 to $200 or more, depending on the dog’s weight and your clinic’s pricing. Over a full year, the range is wide:
- Small dogs: $150 to $600 per year (3 to 12 injections)
- Medium dogs: $300 to $1,200 per year
- Large dogs: $450 to $1,800 per year
- Giant breeds: $600 to $2,400 per year
Dogs with mild seasonal allergies may only need three or four shots a year, while dogs with year-round atopic dermatitis could need monthly injections. The frequency your dog ends up on is the biggest factor in annual cost. Some pet insurance plans cover Cytopoint as a prescription treatment, which can offset the expense significantly for dogs that need it long-term.
Which Dogs Are Good Candidates
Cytopoint is approved for the treatment of allergic and atopic dermatitis in dogs. It’s particularly well-suited for dogs that need ongoing management, since its limited interaction with the immune system makes repeated dosing over months or years less of a concern than with broader immunosuppressive drugs. It’s also a strong option for dogs with liver issues or other conditions where daily oral medications carry more risk, since the antibody is broken down naturally in the body rather than processed through the liver.
Dogs whose itching is primarily driven by IL-31, which is the majority of atopic dogs, tend to respond best. Dogs with itch driven more heavily by other inflammatory pathways may need combination therapy or an alternative approach. If your dog doesn’t show improvement after the first injection, your vet may try a second dose before switching strategies, since some dogs respond more strongly to a subsequent dose.